Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 5, 2005
Cardiac resynchronization therapy (CRT) in heart failure--a model to assess the economic value of this new medical technology
Kurt Banz,
Vaccine
|
August 30, 2008
Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases
Paolo Bonanni, Sara Boccalini, Angela Bechini, et al.
Health Policy (Amsterdam, Netherlands)
|
July 26, 2014
Evaluation of a possible predictor for Federal Joint Committee decisions on early benefit assessments according to the German act on the reform of the market for medicinal products
Björn Schwander, Kurt Banz, Klaus Kaier, et al.
Health Economics Review
|
July 11, 2015
Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluation
Kurt Banz, Peter Paul Delnoy, Jean Renaud Billuart
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
The burden of varicella in Germany. Potential risks and economic impact
Kurt Banz, Stefan Wagenpfeil, Albrecht Neiss, et al.
Medical Microbiology and Immunology
|
November 1, 2002
Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany
Peter Wutzler, Albrecht Neiss, Kurt Banz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 25, 2003
Validation of health economic models: the example of EVITA
Thomas Hammerschmidt, Anita Goertz, Stefan Wagenpfeil, et al.
Human Vaccines
|
October 16, 2009
Economic evaluation of varicella vaccination in Swiss children and adolescents
Kurt Banz, Andrea Iseli, Christoph Aebi, et al.
Human Vaccines
|
October 16, 2009
Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland
Andrea Iseli, Christoph Aebi, Kurt Banz, et al.
Journal of Medical Economics
|
January 30, 2013
Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings
Rebecca L Hancock-Howard, Christopher M Feindel, Josep Rodes-Cabau, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 5, 2005
Cardiac resynchronization therapy (CRT) in heart failure--a model to assess the economic value of this new medical technology
Kurt Banz,
Vaccine
|
August 30, 2008
Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases
Paolo Bonanni, Sara Boccalini, Angela Bechini, et al.
Health Policy (Amsterdam, Netherlands)
|
July 26, 2014
Evaluation of a possible predictor for Federal Joint Committee decisions on early benefit assessments according to the German act on the reform of the market for medicinal products
Björn Schwander, Kurt Banz, Klaus Kaier, et al.
Health Economics Review
|
July 11, 2015
Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluation
Kurt Banz, Peter Paul Delnoy, Jean Renaud Billuart
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
The burden of varicella in Germany. Potential risks and economic impact
Kurt Banz, Stefan Wagenpfeil, Albrecht Neiss, et al.
Medical Microbiology and Immunology
|
November 1, 2002
Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany
Peter Wutzler, Albrecht Neiss, Kurt Banz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 25, 2003
Validation of health economic models: the example of EVITA
Thomas Hammerschmidt, Anita Goertz, Stefan Wagenpfeil, et al.
Human Vaccines
|
October 16, 2009
Economic evaluation of varicella vaccination in Swiss children and adolescents
Kurt Banz, Andrea Iseli, Christoph Aebi, et al.
Human Vaccines
|
October 16, 2009
Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland
Andrea Iseli, Christoph Aebi, Kurt Banz, et al.
Journal of Medical Economics
|
January 30, 2013
Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings
Rebecca L Hancock-Howard, Christopher M Feindel, Josep Rodes-Cabau, et al.
Page
of 2